DIVERSA Technologies Revenue
Biotechnology Research • 
Santiago de Compostela, Galicia, Spain • 21-50 Employees
DIVERSA Technologies revenue & valuation
| Annual revenue | $1,967,765 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $6,300,000 |
| Total funding | No funding |
Key Contacts at DIVERSA Technologies
Maria De La Fuente Freire
Cofounder
Abi J Vázquez
Cofounder / Chief Operating Officer
Company overview
| Headquarters | Santiago de Compostela, Galicia, Spain |
| Website | |
| NAICS | 541714 |
| Keywords | Biotechnology, Nanotechnology, Sirna Delivery, Protein Delivery, Drug Delivery System, Intracellular Delivery, Dna Delivery, Peptide Delivery, Small Molecule Delivery, Mrna Delivery |
| Founded | 2022 |
| Employees | 21-50 |
| Socials |
DIVERSA Technologies Email Formats
DIVERSA Technologies uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@diversatechnologies.com), used 72.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@diversatechnologies.com | 72.7% |
{first initial}.{first4} | j.{first4}@diversatechnologies.com | 18.2% |
{first initial}.{second initial} | j.o@diversatechnologies.com | 9.1% |
About DIVERSA Technologies
Our drug delivery technology based on lipidic nanoemulsions allows for safe and physiological intracellular delivery of complex macromolecules (peptides, proteins and nucleic acids) and small hydrophobic molecules. The platform has broad and fresh IP protection and is fully scalable and regulatory compliant. At DIVERSA, we want to bridge the gap between molecules and patients, between drug discovery and clinical application. We want to create new opportunities to improve patients' quality of life. Despite the discovery of many new targets and therapeutic molecules in labs around the world, less than 3% of them will make it to clinical stages. Most of these new molecules are discarded in the early stages of research, mostly because they cannot access the interior of the cell, where 3 out of 4 new molecules have their targets. We want change that. We want to spearhead the therapeutic revolution.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
DIVERSA Technologies has 9 employees across 5 departments.
Departments
Number of employees
Funding Data
DIVERSA Technologies has never raised funding before.
DIVERSA Technologies Tech Stack
Discover the technologies and tools that power DIVERSA Technologies's digital infrastructure, from frameworks to analytics platforms.
Reverse proxies
Programming languages
Security
Blogs
Databases
Portugal
United Kingdom
United States
Italy
South AfricaFrequently asked questions
4.8
40,000 users
